Search results
Review: Anne Hathaway sells the kismet connection in ‘The Idea of You’ - LA Weekly
LA Weekly· 6 days agoHe's just a guy, staring at a girl, telling her that he loves her. Well, he's actually a musician...
ALLEGANY MAGAZINE ONLINE REVIEW: Cumberland Theatre offers a "Modern Parable" with Jesus Christ...
Cumberland Times-News· 5 days agoWhen watching Jesus Christ, Superstar at The Cumberland Theatre , the first adage I thought of was,...
Victrix Pro BFG for Xbox review: "Floats like a butterfly and stings like a bee"
Games Radar· 1 day agoWhere do I begin with the Victrix Pro BFG for Xbox? In my time as hardware editor here at...
A Home Design Visualizer With Ready-to-Buy Materials Can Transform Your Curb Appeal
Men's Journal· 2 hours agoThis design tool includes palettes selected by some of America's favorite home designers. With...
Fiction: ‘This Strange Eventful History’ by Claire Messud
The Wall Street Journal· 6 days agoAn exemplar of the paradigm, “This Strange Eventful History” is a kind of epic of inaction, and...
Apple Apologizes for Widely-Criticized iPad Ad
Men's Journal· 4 days agoApple's destructive commercial for its new iPad wasn't exactly a hit with the creatives it was trying to target, and the company has now issued a rare...
New Clinical Guidance for Sjögren-Related Neuropathy
Medscape· 7 days agoSarka discussed the initiative on April 17 at the American Academy of Neurology (AAN) 2024 Annual Meeting...
Immuneering’s (IMRX) “Buy” Rating Reiterated at Needham & Company LLC
ETF DAILY NEWS· 4 days agoNeedham & Company LLC restated their buy rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a ...
Orlando Ballet’s longest-serving dancer hangs up her slippers
Orlando Sentinel· 1 day agoAnamarie McGinn is following the showbiz adage, “Always leave them wanting more.” The...
Earnings call: Immunic outlines progress and financials for Q1 2024
Investing.com· 6 days agoImmunic, Inc. (NASDAQ: IMUX ) reported a loss in the first quarter of 2024 but showcased progress in...